Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Shareholder Notice: Investigation over Potential Wrongdoing
An investigation for investors in NASDAQ:REGN shares was announced over potential breaches of fiduciary duties by certain officers and directors at Regeneron Pharmaceuticals.
View full press release